Boehringer Ingelheim Vetera VEWT + WNV Equine Vaccine 1 ml/1 Dose

Horse

Boehringer Ingelheim Vetera VEWT + WNV Equine Vaccine 1 mL/1 Dose At least 12 month WNV DOI Safe for use in horses as young as 4 months of age, including pregnant mares Contains equine origin 2005 West Nile Virus isolate (E159 ) strain Incorporates the Carbimmune adjuvant formulation to optimize performance and minimize reactions Unique ULTRAFIL purification technology minimizes nonrelevant protein presented to the immune system Combination vaccine that includes protection against Eastern, Western, and Venezuelan encephalomyelitis, West Nile Virus and Tetanus Available in single dose pre-filled syringes or color-coded 10 dose vials Features At least 12 month WNV DOI Safe for use in horses as young as 4 months of age, including pregnant mares Contains equine origin 2005 West Nile Virus isolate (E159 ) Incorporates the Carbimmune adjuvant formulation Unique ULTRAFIL purification technology Benefits Contains equine origin 2005 West Nile Virus isolate (E159 ) – the strain most likely to infect horses today. Adjuvant formulation specifically customized to optimize performance and minimize reactions Purification process minimizes non relative protein being presented to the immune system Shake well before use. Using aseptic technique, inoculate horses intramuscularly with a 1 mL dose. Administer a second 1 mL dose intramuscularly in 3-4 weeks using a different injection site. Revaccinate annually and prior to anticipated exposure with a single 1 mL intramuscular dose.